{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:27:38Z","timestamp":1772310458821,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81871606"],"award-info":[{"award-number":["No.81871606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["No. KJQN201900435"],"award-info":[{"award-number":["No. KJQN201900435"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11033-022-08086-6","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T12:14:38Z","timestamp":1670847278000},"page":"1477-1485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Janus kinase inhibitor Tofacitinib alleviated acute hepatitis induced by lipopolysaccharide\/D-galactosamine in mice"],"prefix":"10.1007","volume":"50","author":[{"given":"Xinyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyue","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"8086_CR1","doi-asserted-by":"crossref","unstructured":"Bernal W, Auzinger G, Dhawan A et al (2010) Acute liver failure.Lancet190\u2013201","DOI":"10.1016\/S0140-6736(10)60274-7"},{"issue":"2","key":"8086_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","volume":"67","author":"E Triantafyllou","year":"2018","unstructured":"Triantafyllou E, Pop OT, Possamai LA et al (2018) MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut Feb 67(2):333\u2013347","journal-title":"Gut Feb"},{"issue":"5","key":"8086_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","volume":"20","author":"VAK Rathinam","year":"2019","unstructured":"Rathinam VAK, Zhao Y, Shao F (2019) Innate immunity to intracellular LPS. Nat Immunol May 20(5):527\u2013533","journal-title":"Nat Immunol May"},{"issue":"1","key":"8086_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00002371-199102000-00010","volume":"10","author":"TG Elliott","year":"1991","unstructured":"Elliott TG, Welty D et al (1991) The D-Galactosamine Loaded Mouse and Its Enhanced Sensitivity to Lipopolysaccharide and Monophosphoryl Lipid A: A Role for Superoxide. J Immunother 10(1):69\u201374","journal-title":"J Immunother"},{"key":"8086_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1476-5381.1992.tb14542.x","volume":"107","author":"TKM Yasuo Endo, Nakamura","year":"1992","unstructured":"Yasuo Endo, Nakamura TKM (1992) Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine. Br J Pharmacol 107:888\u2013894","journal-title":"Br J Pharmacol"},{"issue":"11","key":"8086_CR6","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","volume":"76","author":"C Galanos","year":"1979","unstructured":"Galanos C, Freudenberg MA, Reutter W (1979) Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A Nov 76(11):5939\u20135943","journal-title":"Proc Natl Acad Sci U S A Nov"},{"issue":"2","key":"8086_CR7","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10753-020-01349-z","volume":"44","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang J, Zhang Y et al (2021) Pterostilbene Exerts Hepatoprotective Effects through Ameliorating LPS\/D-Gal-Induced Acute Liver Injury in Mice. Inflamm Apr 44(2):526\u2013535","journal-title":"Inflamm Apr"},{"issue":"93","key":"8086_CR8","first-page":"962","volume":"9","author":"J Huanjin Liao","year":"2017","unstructured":"Huanjin Liao J, Cai L, Zhang et al (2017) A novel acute lethal liver injury mouse model with visualization of NF-\u03baB activity for treatment of severe acute liver injury. Am J Transl Res 9(93):962\u2013970","journal-title":"Am J Transl Res"},{"issue":"5","key":"8086_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M et al (2017) JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs Apr 77(5):521\u2013546","journal-title":"Drugs Apr"},{"key":"8086_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski Jr","year":"2016","unstructured":"Roskoski R Jr (2016) Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res Sep 111:784\u2013803","journal-title":"Pharmacol Res Sep"},{"issue":"12","key":"8086_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A et al (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discovery 16(12):843\u2013862","journal-title":"Nat Rev Drug Discovery"},{"key":"8086_CR12","first-page":"1","volume":"86","author":"Y Li","year":"2020","unstructured":"Li Y, Liu X, Yu J et al (2020) Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis. Int Immunopharmacol Sep 86:1\u201310","journal-title":"Int Immunopharmacol Sep"},{"issue":"1","key":"8086_CR13","first-page":"1","volume":"210","author":"A Jarneborn","year":"2020","unstructured":"Jarneborn A, Mohammad M, Engdahl C et al (2020) Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice. Sci Rep Jul 210(1):1\u201314","journal-title":"Sci Rep Jul"},{"key":"8086_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cbi.2014.06.017","volume":"5","author":"SH Hazem","year":"2014","unstructured":"Hazem SH, Shaker ME, Ashamallah SA et al (2014) The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms. Chemico-biological Interact Sep 5:220:116\u2013127","journal-title":"Chemico-biological Interact Sep"},{"key":"8086_CR15","doi-asserted-by":"publisher","first-page":"108463","DOI":"10.1016\/j.intimp.2021.108463","volume":"103","author":"ME Shaker","year":"2022","unstructured":"Shaker ME, Hendawy OM, El-Mesery M et al (2022) The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice. Int Immunopharmacol Feb 103:108463","journal-title":"Int Immunopharmacol Feb"},{"issue":"2","key":"8086_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jbspin.2019.09.005","volume":"87","author":"T El Jammal","year":"2020","unstructured":"El Jammal T, Gerfaud-Valentin M, Seve P et al (2020) Inhibition of JAK\/STAT signaling in rheumatologic disorders: The expanding spectrum. Joint Bone Spine Mar 87(2):119\u2013129","journal-title":"Joint Bone Spine Mar"},{"issue":"34","key":"8086_CR17","first-page":"318","volume":"11","author":"JA Hodge","year":"2016","unstructured":"Hodge JA, Kawabata TT, Krishnaswami S et al (2016) The mechanism of action of tofacitinib \u2013 an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 11(34):318\u2013328","journal-title":"Clin Exp Rheumatol"},{"key":"8086_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8877056","volume":"2021","author":"Y Yun","year":"2021","unstructured":"Yun Y, Chen J, Wang X et al (2021) Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1\/STAT3 Signaling Pathway. Biomed Res Int 2021:1\u20139","journal-title":"Biomed Res Int"},{"issue":"1","key":"8086_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","volume":"147","author":"M Robles\u2013Diaz","year":"2014","unstructured":"Robles\u2013Diaz M, Lucena MI, Kaplowitz N et al (2014) Use of Hy\u2019s Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury. Gastroenterology 147(1):109\u2013118e5","journal-title":"Gastroenterology"},{"issue":"2","key":"8086_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00441-015-2252-2","volume":"363","author":"P Yang","year":"2016","unstructured":"Yang P, Zhou W, Li C et al (2016) Kupffer-cell-expressed transmembrane TNF-alpha is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury. Cell Tissue Res Feb 363(2):371\u2013383","journal-title":"Cell Tissue Res Feb"},{"key":"8086_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.intimp.2017.08.009","volume":"51","author":"L Li","year":"2017","unstructured":"Li L, Duan C, Zhao Y et al (2017) Preventive effects of interleukin-6 in lipopolysaccharide\/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages. Int Immunopharmacol Oct 51:99\u2013106","journal-title":"Int Immunopharmacol Oct"},{"issue":"1","key":"8086_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/smim.1996.0058","volume":"9","author":"DK Miller","year":"1997","unstructured":"Miller DK (1997) The role of the Caspase family of cysteine proteases in apoptosis. Semin Immunol Feb 9(1):35\u201349","journal-title":"Semin Immunol Feb"},{"issue":"11","key":"8086_CR23","first-page":"1","volume":"18","author":"Y Jamilloux","year":"2019","unstructured":"Jamilloux Y, El Jammal T, Vuitton L et al (2019) JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev Nov 18(11):1\u201361","journal-title":"Autoimmun Rev Nov"},{"issue":"1","key":"8086_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40259-019-00333-w","volume":"33","author":"ATV Haikarainen","year":"2019","unstructured":"Haikarainen ATV, Raivola T et al (2019) Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases. BioDrugs Feb 33(1):15\u201332","journal-title":"BioDrugs Feb"},{"key":"8086_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pupt.2017.01.002","volume":"43","author":"E Calama","year":"2017","unstructured":"Calama E, Ramis I, Domenech A et al (2017) Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS. Pulm Pharmacol Ther Apr 43:60\u201367","journal-title":"Pulm Pharmacol Ther Apr"},{"issue":"12","key":"8086_CR26","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","volume":"27","author":"R Morris","year":"2018","unstructured":"Morris R, Kershaw NJ, Babon JJ (2018) The molecular details of cytokine signaling via the JAK\/STAT pathway. Protein Sci Dec 27(12):1984\u20132009","journal-title":"Protein Sci Dec"},{"key":"8086_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O\u2019Shea","year":"2015","unstructured":"O\u2019Shea JJ, Schwartz DM, Villarino AV et al (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311\u2013328","journal-title":"Annu Rev Med"},{"issue":"6","key":"8086_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","volume":"17","author":"A Salas","year":"2020","unstructured":"Salas A, Hernandez-Rocha C, Duijvestein M et al (2020) JAK-STAT pathway targeting for the treatment of inflammatory bowel disease. Nat reviews Gastroenterol Hepatol Jun 17(6):323\u2013337","journal-title":"Nat reviews Gastroenterol Hepatol Jun"},{"issue":"21","key":"8086_CR29","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"13","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H et al (2022) The JAK-STAT pathway at 30: Much learned, much more to do. Cell Oct 13(21):3857\u20133876","journal-title":"Cell Oct"},{"issue":"5","key":"8086_CR30","doi-asserted-by":"publisher","first-page":"L868","DOI":"10.1152\/ajplung.00281.2016","volume":"1","author":"J Zhao","year":"2016","unstructured":"Zhao J, Yu H, Liu Y et al (2016) Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol Nov 1(5):L868\u2013L880","journal-title":"Am J Physiol Lung Cell Mol Physiol Nov"},{"key":"8086_CR31","doi-asserted-by":"publisher","first-page":"G761","DOI":"10.1152\/ajpgi.00224.2003","volume":"8","author":"W-H Kim","year":"2003","unstructured":"Kim W-H, Radaeva FHongS et al (2003) STAT1 plays an essential role in LPS\/D-galactosamine-induced liver apoptosis and injury. Am J Physiol Gastrointest Liver Physiol 8:G761\u2013G768","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"8086_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jhep.2010.05.029","volume":"53","author":"ML Olleros","year":"2010","unstructured":"Olleros ML, Vesin D, Fotio AL et al (2010) Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis. J Hepatol Dec 53(6):1059\u20131068","journal-title":"J Hepatol Dec"},{"issue":"7","key":"8086_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00011-013-0633-0","volume":"62","author":"H Zelova","year":"2013","unstructured":"Zelova H, Hosek J (2013) TNF-alpha signalling and inflammation: interactions between old acquaintances. Inflamm Res Jul 62(7):641\u2013651","journal-title":"Inflamm Res Jul"},{"issue":"22","key":"8086_CR34","first-page":"11740","volume":"24","author":"L Jin","year":"2020","unstructured":"Jin L, Cai CL, Lang XL et al (2020) Ghrelin inhibits inflammatory response and apoptosis of myocardial injury in septic rats through JAK\/STAT signaling pathway. Eur Rev Med Pharmacol Sci 24(22):11740\u201311746","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"8086_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/lt.22036","volume":"16","author":"MC Freitas","year":"2010","unstructured":"Freitas MC, Uchida Y, Zhao D et al (2010) Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl May 16(5):600\u2013610","journal-title":"Liver Transpl May"},{"issue":"1","key":"8086_CR36","first-page":"1","volume":"312","author":"SP Totten","year":"2021","unstructured":"Totten SP, Im YK, Canedo EC et al (2021) STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer. Nat Commun Jun 312(1):1\u201320","journal-title":"Nat Commun Jun"},{"issue":"1","key":"8086_CR37","first-page":"305","volume":"52","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yu X, Song H et al (2018) The STAT-ROS cycle extends IFNinduced cancer cell apoptosis. Int J Oncol Jan 52(1):305\u2013313","journal-title":"Int J Oncol Jan"},{"key":"8086_CR38","first-page":"1","volume":"125","author":"X Peng","year":"2020","unstructured":"Peng X, Yang Y, Tang L et al (2020) Therapeutic benefits of apocynin in mice with lipopolysaccharide\/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK\/JNK pathway. Biomed Pharmacother May 125:1\u20139","journal-title":"Biomed Pharmacother May"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T18:06:13Z","timestamp":1675188373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["8086"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08086-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"30 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest concerning the research, authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments in this study were approved by the Ethics Committee of Chongqing Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The data supporting this study\u2019s findings are available from the corresponding author (fyyyq1984@cqmu.edu.cn) upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data accessibility"}}]}}